Drug companies succeed in keeping payments to doctors secretBMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7426.1248-a (Published 27 November 2003) Cite this as: BMJ 2003;327:1248
- Bob Burton
Lobbying by Australia's drug industry association, Medicines Australia, has persuaded the Australian Competition and Consumer Commission (ACCC) to scrap a proposal to require public disclosure of drug companies' sponsorship of doctors' travel and accommodation and other promotional benefits.
The commission, a government agency established to protect consumers from anticompetitive activity, had originally proposed accrediting a self regulatory code on the marketing of drugs developed by Medicines Australia member companies, subject to certain amendments.
The first amendment laid down that Medicines Australia publish details of all breaches of the code on its website in full and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial